Cannabis Has Opposite Effects on Brain Signal Processing in Schizophrenia Patients Versus Healthy People
Chronic cannabis use impaired a measure of brain signal filtering (P200 suppression) in healthy people but paradoxically improved it in schizophrenia patients, suggesting the endocannabinoid system functions differently in schizophrenia.
Quick Facts
What This Study Found
Researchers measured how the brain filters repeated auditory signals in four groups: schizophrenia patients with and without cannabis use, and healthy controls with and without cannabis use. They focused on "repetition suppression," where the brain normally dampens its response to a repeated sound.
For the P200 brain wave component, cannabis had opposite effects depending on diagnosis. In healthy controls, chronic cannabis use was associated with worse suppression (0.55 vs. 0.40, p < 0.02), meaning poorer signal filtering. In schizophrenia patients, cannabis use was associated with better suppression (0.36 vs. 0.54, p < 0.02), meaning improved signal filtering.
Among healthy controls, total lifetime cannabis consumption correlated with worse P200 suppression (r = 0.28, p < 0.007). Among schizophrenia patients, longer time since last cannabis use correlated with worse P200 suppression (r = 0.42, p < 0.002), suggesting the benefit faded with abstinence.
Key Numbers
34 schizophrenia patients with cannabis, 33 without. 45 controls with cannabis, 61 without. Interaction between diagnosis and cannabis on P200 suppression: p < 0.001. Cannabis-using controls: suppression ratio 0.55. Non-using controls: 0.40. Cannabis-using schizophrenia: 0.36. Non-using schizophrenia: 0.54.
How They Did This
Mixed-sample study with 34 schizophrenia patients and 45 healthy controls who were chronic heavy cannabis users, plus 33 schizophrenia patients and 61 healthy controls without cannabis use. Auditory event-related potentials were recorded using a paired-stimulus paradigm measuring P50, N100, and P200 repetition suppression.
Why This Research Matters
This study provides neurophysiological evidence for the paradox of cannabis use in schizophrenia: while cannabis is a risk factor for psychosis, many patients report subjective benefits. The opposing effects on P200 suppression suggest that the endocannabinoid system may be fundamentally altered in schizophrenia, meaning cannabis interacts with a different neurological landscape in these patients.
The Bigger Picture
The relationship between cannabis and schizophrenia is not simply "cannabis causes psychosis." This study reveals that the neurobiological effects of cannabis differ fundamentally between healthy brains and brains affected by schizophrenia. This divergence likely reflects underlying alterations in the endocannabinoid system that are part of schizophrenia itself, not just a consequence of cannabis use.
What This Study Doesn't Tell Us
Cross-sectional design cannot determine causation. Cannabis users in both groups may differ from non-users in ways beyond cannabis exposure (other substance use, medication differences). P200 suppression is one of many possible measures of sensory processing, and its clinical relevance is debated. The study measured chronic heavy use and did not assess the effects of different doses or patterns of use.
Questions This Raises
- ?Could endocannabinoid system abnormalities in schizophrenia be a target for treatment?
- ?Does the paradoxical improvement in P200 suppression with cannabis in schizophrenia translate to any functional benefit?
- ?Would targeted cannabinoid therapies improve sensory processing in schizophrenia without the risks of cannabis use?
Trust & Context
- Key Stat:
- Cannabis improved P200 suppression in schizophrenia (p < 0.02) but impaired it in healthy controls (p < 0.02)
- Evidence Grade:
- Moderate evidence from a well-designed case-control study with adequate sample sizes, though limited by cross-sectional design.
- Study Age:
- Published in 2017. Contributes to understanding of endocannabinoid system alterations in schizophrenia.
- Original Title:
- Opposing Effects of Cannabis Use on Late Auditory Repetition Suppression in Schizophrenia Patients and Healthy Control Subjects.
- Published In:
- Biological psychiatry. Cognitive neuroscience and neuroimaging, 2(3), 263-271 (2017)
- Authors:
- Rentzsch, Johannes(3), Kronenberg, Golo(2), Stadtmann, Ada(2), Neuhaus, Andres, Montag, Christiane, Hellweg, Rainer, Jockers-Scherübl, Maria Christiane
- Database ID:
- RTHC-01499
Evidence Hierarchy
Compares people with a condition to similar people without it.
What do these levels mean? →Frequently Asked Questions
Does this mean cannabis helps schizophrenia?
Not exactly. The study found that cannabis improved one specific measure of brain signal processing in schizophrenia patients. However, cannabis use remains associated with overall worse outcomes in schizophrenia, including more frequent psychotic episodes and hospitalizations. One positive neurophysiological finding does not outweigh the established risks.
Why would cannabis have opposite effects in healthy versus schizophrenia brains?
The researchers suggest this reflects underlying alterations in the endocannabinoid system that are part of schizophrenia. In a healthy brain, cannabis disrupts normal endocannabinoid signaling. In schizophrenia, where the system is already altered, cannabis may partially compensate for existing deficits in certain neural circuits.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01499APA
Rentzsch, Johannes; Kronenberg, Golo; Stadtmann, Ada; Neuhaus, Andres; Montag, Christiane; Hellweg, Rainer; Jockers-Scherübl, Maria Christiane. (2017). Opposing Effects of Cannabis Use on Late Auditory Repetition Suppression in Schizophrenia Patients and Healthy Control Subjects.. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2(3), 263-271. https://doi.org/10.1016/j.bpsc.2016.10.004
MLA
Rentzsch, Johannes, et al. "Opposing Effects of Cannabis Use on Late Auditory Repetition Suppression in Schizophrenia Patients and Healthy Control Subjects.." Biological psychiatry. Cognitive neuroscience and neuroimaging, 2017. https://doi.org/10.1016/j.bpsc.2016.10.004
RethinkTHC
RethinkTHC Research Database. "Opposing Effects of Cannabis Use on Late Auditory Repetition..." RTHC-01499. Retrieved from https://rethinkthc.com/research/rentzsch-2017-opposing-effects-of-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.